TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover | 0 | 3,921 | 0 |
Financial expenses | 2,542 | 5,804 | 2,499 |
Earnings before taxes | -12,387 | -42,538 | -38,934 |
EBITDA | -9,850 | -36,735 | -36,436 |
Total assets | 48,997 | 80,369 | 86,026 |
Current assets | 48,979 | 27,236 | 20,216 |
Current liabilities | 21,369 | 29,301 | 34,811 |
Equity capital | 27,627 | 50,839 | 50,472 |
- share capital | 1,192 | 873 | 628 |
Employees (average) | 7 | 8 | 6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency | 56.4% | 63.3% | 58.7% |
Turnover per employee | 0 | 490 | 0 |
Profit as a percentage of turnover | -1084.9% | ||
Return on assets (ROA) | -20.1% | -45.7% | -42.4% |
Current ratio | 229.2% | 93.0% | 58.1% |
Return on equity (ROE) | -44.8% | -83.7% | -77.1% |
Change turnover | -3,941 | 3,921 | 0 |
Change turnover % | -100% | ||
Chg. No. of employees | -1 | 2 | 0 |
Chg. No. of employees % | -13% | 33% | 0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.